title: Adrenoleukodystrophy. Value of contrast-enhanced MR imaging.
abstract: In its early stage adrenoleukodystrophy (ALD) is characterized by hypodensity at CT and signal abnormalities at RMI (low-intensity signal on T1-weighted sequences, high-intensity signal on T2-weighted sequences) in the white matter of the parieto-occipital region and the splenium of the corpus callosum. These CT and RMI abnormalities are suggestive of ALD in children with progressive alteration of the superior brain functions, but they are not specific of the disease. The authors present two cases of ALD and underline the almost pathognomonic value of contrast-enhanced ribbons found at the periphery of low-intensity signal plaques after gadolinium injection. These areas of blood-barrier disruption on a background of inflammation and active demyelination appear, on T2-weighted sequences, as ribbons of low-intensity signal within plaques of high-intensity signal. MRI is also superior to CT in detecting abnormalities located in the posterior fossa, notably lesions of the auditory fibres.
authors.affiliation: Service de Radiologie B (Unité de Neuroradiologie et de Scanographie), Hospices Civils, Universitaire de Strasbourg, France.
authors.forename: C
authors.initials: C
authors.lastname: Romero
authors.forename: J L
authors.initials: JL
authors.lastname: Dietemann
authors.forename: D
authors.initials: D
authors.lastname: Kurtz
authors.forename: M
authors.initials: M
authors.lastname: Bataillard
authors.forename: D
authors.initials: D
authors.lastname: Christmann
mesh_terms: D000326:Adrenoleukodystrophy / Q000175:diagnosis* / Q000000981:diagnostic imaging; D002648:Child; D003287:Contrast Media; D005682:Gadolinium; D006571:Heterocyclic Compounds; D006801:Humans; D007089:Image Enhancement / Q000379:methods; D007455:Iodine; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D009942:Organometallic Compounds; D011856:Radiographic Image Enhancement; D014057:Tomography, X-Ray Computed
chemical_list: D003287:Contrast Media; D006571:Heterocyclic Compounds; D009942:Organometallic Compounds; D007455:Iodine; C050823:gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate; D005682:Gadolinium